DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
DRNA
Delisted
DRNA was delisted on the 27th of December, 2021.
98 hedge funds and large institutions have $866M invested in Dicerna Pharmaceuticals, Inc. in 2019 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 35 increasing their positions, 24 reducing their positions, and 24 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
98
Holders Change
-5
Holders Change %
-4.85%
% of All Funds
2.12%
Holding in Top 10
5
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-16.67%
% of All Funds
0.11%
New
19
Increased
35
Reduced
24
Closed
24
Calls
$1K
Puts
$1K
Net Calls
–
Net Calls Change
-$132K
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
$35.4M |
| 2 |
Point72 Asset Management
Stamford,
Connecticut
|
$19.8M |
| 3 |
Carson Wealth (CWM LLC)
Omaha,
Nebraska
|
$8.08M |
| 4 |
AG
Artal Group
Luxembourg
|
$14.3M |
| 5 |
JPMorgan Chase & Co
New York
|
$6.53M |
